Natriumkromoglikat Abece (Sodium Cromoglicate)

Sodium cromoglicate, the active ingredient in Natriumkromoglikat Abece, is a mast cell stabilizer presented as an ophthalmic solution for ocular use. It is employed to treat allergic conjunctivitis and vernal keratoconjunctivitis, helping to reduce eye itching, redness, and swelling in patients with allergic eye disease.

GNH USA supplies Natriumkromoglikat Abece as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows EU GMP standards and provides reliable, temperature‑controlled logistics for global distribution.

Sodium cromoglicate is used in ophthalmology to manage allergic eye conditions by stabilizing mast cells.

- Allergic conjunctivitis: reduces ocular itching, redness and swelling. - Vernal keratoconjunctivitis: prevents mast cell degranulation and improves chronic symptoms. - Seasonal allergic eye disease: stabilizes mast cells to lessen inflammation and discomfort.

Adverse ocular and systemic reactions have been reported with sodium cromoglicate eye drops.

Common Side Effects: - Eye irritation: mild burning or stinging on instillation. - Blurred vision: temporary visual disturbance after dosing. - Taste disturbance: bitter taste when solution drains through nasolacrimal duct. - Headache: mild headache in some patients. - Ocular discomfort: sensation of foreign body.

Serious or Rare Side Effects: - Severe allergic reaction: angioedema or anaphylaxis requiring immediate medical attention. - Eye infection: bacterial or fungal infection secondary to compromised ocular surface. - Corneal ulcer: rare ulceration that may threaten vision. - Vision loss: abrupt loss of visual acuity, urgent evaluation needed. - Persistent redness: prolonged inflammation indicating possible complication.

When prescribing sodium cromoglicate eye drops, consider the following precautions to ensure safe use.

- Assess patient history: check for known hypersensitivity to sodium cromoglicate or formulation excipients. - Avoid concurrent ocular surgery: discontinue use prior to procedures to prevent interference with healing. - Monitor for ocular irritation: advise patients to report persistent burning or redness. - Use with caution in children: pediatric safety data are limited; evaluate risk‑benefit. - Store at room temperature: keep in original container, protect from light and moisture.

Sodium cromoglicate may interact with other ophthalmic or systemic agents.

Major Interactions (Avoid): - Preservative‑rich antihistamine drops: may increase ocular irritation. - Topical corticosteroids: concurrent use can mask signs of infection. - Multiple mast cell stabilizers: no added benefit and may heighten local discomfort.

Moderate Interactions (Monitor Closely): - Systemic antihistamines: may reduce tear production, monitor for dry eye. - Contact lens wear: lenses can trap the solution, advise removal during treatment.